Department of Infectious Diseases, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
Statistics and Data Management Center, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
Microbiol Spectr. 2022 Apr 27;10(2):e0002622. doi: 10.1128/spectrum.00026-22. Epub 2022 Mar 21.
Consolidation is one complication of pediatric severe community-acquired pneumonia (SCAP) that can respond poorly to conservative medical treatment. We investigated the pathogens that cause pediatric SCAP including cases with persistent consolidation that need bronchoscopy intervention. Alveolar lavage fluid (ALF) samples collected from cases admitted to Children's Hospital of Fudan University with SCAP during January 2019 to March in 2019 were retrospectively tested by the RespiFinder 2SMART multiplex PCR (multi-PCR) assay targeting 22 respiratory pathogens. A total of 90 cases and 91 samples were enrolled; 80.0% (72/90) of the cases had pulmonary consolidation and/or atelectasis. All samples were positive with targeted pathogens tested by multi-PCR, and 92.3% (84/91) of the samples were co-detected with pathogens. Mycoplasma pneumoniae (MP) and (ADV) as the two dominant pathogens, with the positive rates of 96.7% (88/91) and 79.1% (72/91), respectively. Most of the samples were positive with MP and ADV simultaneously. As a control, 78.0% (71/91) of the samples were positive by conventional tests (CT), in which MP had the detection rate of 63.9% (55/86) by a traditional real-time PCR assay, while ADV were positive in 13.1% (12/91) of the samples by a direct immunofluorescence assay (DFA). In cases with persistent pulmonary consolidation, the positive rates of pathogens by multi-PCR and CT were 100% (72/72) and 81.9% (59/72), respectively. There were no significant differences of MP or ADV positive rates between cases with and without pulmonary consolidation. MP and ADV most prevalent in pediatric SCAP cases required fiberscope intervention, and presented with coinfections dominantly. Pathogens that cause pediatric severe community-acquired pneumonia (SCAP) requiring bronchoscopy intervention are understudied. Through this study, we explore the etiology of SCAP form alveolar lavage fluid (ALF) samples by the RespiFinder 2SMART multi-PCR assay. It is observed that high mixed detection rates of Mycoplasma pneumoniae and in ALF samples collected from hospitalized SCAP children experienced bronchoscopy intervention. Eighty percent of the cases had pulmonary consolidation and/or atelectasis. The presence of possible coinfection of these two pathogens might contribute to poor clinical anti-infection response. The results of this study might be helpful for the selection of clinical strategies for the empirical treatment of such pediatric SCAP cases.
巩固是儿科重症社区获得性肺炎(SCAP)的一种并发症,可能对保守的医学治疗反应不佳。我们研究了引起儿科 SCAP 的病原体,包括需要支气管镜介入治疗的持续存在的巩固病例。2019 年 1 月至 3 月期间,复旦大学附属儿科医院收治的 SCAP 患儿的肺泡灌洗液(ALF)样本通过针对 22 种呼吸道病原体的 RespiFinder 2SMART 多重 PCR(multi-PCR)检测进行回顾性检测。共纳入 90 例 91 份样本;80.0%(72/90)的病例有肺部实变和/或肺不张。所有样本经 multi-PCR 检测均为目标病原体阳性,92.3%(84/91)的样本同时检测到病原体。肺炎支原体(MP)和 (ADV)为两种主要病原体,阳性率分别为 96.7%(88/91)和 79.1%(72/91)。大多数样本同时检测到 MP 和 ADV 阳性。作为对照,78.0%(71/91)的样本通过常规检测(CT)呈阳性,其中传统实时 PCR 检测的 MP 检出率为 63.9%(55/86),而直接免疫荧光法(DFA)检测到 13.1%(12/91)的 ADV 阳性。在持续肺部实变的病例中,multi-PCR 和 CT 检测病原体的阳性率分别为 100%(72/72)和 81.9%(59/72)。有肺部实变和无肺部实变的病例中 MP 或 ADV 的阳性率无显著差异。需要纤维支气管镜介入治疗的儿科 SCAP 病例中,MP 和 ADV 最为常见,以合并感染为主。需要纤维支气管镜介入治疗的儿科重症社区获得性肺炎(SCAP)的病原体研究较少。通过本研究,我们从肺泡灌洗液(ALF)样本中通过 RespiFinder 2SMART 多重 PCR 检测探索 SCAP 病因。观察到,住院 SCAP 患儿支气管镜介入治疗后 ALF 样本中肺炎支原体和 混合高检出率。80%的病例有肺部实变和/或肺不张。这两种病原体可能存在合并感染,这可能导致抗感染治疗反应不佳。本研究结果可能有助于选择此类儿科 SCAP 病例的经验性治疗临床策略。